![Emily Anne Scraggs](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Emily Anne Scraggs
Directeur/Membre du Conseil chez
Talisman Therapeutics Ltd.
Profil
Emily Anne Scraggs is the founder of Gen2 Neuroscience Ltd., which was founded in 2016.
She held the title of Director at the company.
Currently, she is a Director & Commercial Director at Talisman Therapeutics Ltd.
Postes actifs de Emily Anne Scraggs
| Sociétés | Poste | Début |
|---|---|---|
Talisman Therapeutics Ltd.
 Talisman Therapeutics Ltd. BiotechnologyHealth Technology Operates as stem cell research and development company | Directeur/Membre du Conseil | - |
Anciens postes connus de Emily Anne Scraggs
| Sociétés | Poste | Fin |
|---|---|---|
Gen2 Neuroscience Ltd.
 Gen2 Neuroscience Ltd. Pharmaceuticals: GenericHealth Technology Develops novel treatments for dementia targeting abnormal forms of the essential cellular protein tau | Fondateur | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
2
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Talisman Therapeutics Ltd.
Talisman Therapeutics Ltd. BiotechnologyHealth Technology Operates as stem cell research and development company | Health Technology |
Gen2 Neuroscience Ltd.
Gen2 Neuroscience Ltd. Pharmaceuticals: GenericHealth Technology Develops novel treatments for dementia targeting abnormal forms of the essential cellular protein tau | Health Technology |
Choisissez Zonebourse 
